Results 71 to 80 of about 9,670 (235)
Clinical Case Reports, 2023 Key Clinical Message This case report highlights the potential of belinostat for the treatment of relapsed/refractory peripheral T‐cell lymphomas, for which effective therapies are still scarce.
Vincent Camus +16 more
doaj +1 more source
Angioimmunoblastic T-Cell Lymphoma: A Case Report
Cureus, 2022 Previously believed to be an exaggerated immune response and not a lymphoma, angioimmunoblastic T-cell lymphoma (AITL) is now recognized as a rare variant of peripheral T-cell lymphoma with an aggressive clinical course and poor response to current therapies.
Miles, Brittany +3 more
openaire +2 more sources
Cancer Medicine, Volume 15, Issue 1, January 2026.ICOS (inducible T‐cell co‐stimulator) and ICOS ligand (ICOSL) are part of an important, complex pathway that can lead to both immune stimulation and suppression. Both ICOS agonists and antagonists are under development as oncology therapeutics and biomarker driven approaches will be important to ascertain which patients will derive the greatest benefit
Mina Nikanjam +9 more
wiley +1 more source
Gastric cancer is the leading cause of death in Italian adult patients with common variable immunodeficiency [PDF]
, 2018 An increased prevalence of malignant lymphoma and of gastric cancer has been observed in large cohorts of patients with common variable immunodeficiency (CVID), the most frequently symptomatic primary immunodeficiency. Surveillance strategies for cancers
Agostini, Carlo +11 more
core +3 more sources
Cancer Cytopathology, Volume 134, Issue 1, January 2026.Abstract The objective of the recently published World Health Organization Reporting System for Lymph Node, Spleen, and Thymus Cytopathology (WHO system) is to standardize the diagnostic approach to fine‐needle aspiration biopsies of hematolymphoid tissues.
Mats Ehinger +4 more
wiley +1 more source
Recurrent presence of the PLCG1 S345F mutation in nodal peripheral T-cell lymphomas [PDF]
, 2015 This work was supported by grants from Asociación Española contra el Cancer (AECC), Ministerio de Economía y Competitividad (MINECO) (SAF2013-47416-R), Instituto Salud Carlos III (ISCIII) – Fondos FEDER, MINECO-AES(RD012/0036/0060, PI10/00621, CP11 ...
Arrinda, José M. +21 more
core +2 more sources
Unravelling Subtleties of Angioimmunoblastic T-Cell Lymphoma [PDF]
Journal of Oncology Practice, 2019 International ...
Bachy, Emmanuel, Salles, Gilles
openaire +3 more sources
The Early Diagnostic Dilemma in Angioimmunoblastic T Cell Lymphoma with Excessive Plasma Cells Proliferation [PDF]
, 2021 Chunyan Wang +7 more
openalex +1 more source
Peripheral Lymphocytosis in Angioimmunoblastic T-cell Lymphoma
International Journal of Advanced Medical and Health ResearchAngioimmunoblastic T-cell lymphoma (AITL) is an aggressive and unique type of T-cell lymphoma. Patients typically present with constitutional B symptoms, generalized lymphadenopathy, hepatosplenomegaly, cytopenias, and rash.
C. Selvapriya +4 more
doaj +1 more source